|
市場調査レポート
商品コード
1102134
インターベンショナルオンコロジーの世界市場－市場規模、シェア、業界動向：がんタイプ別、製品タイプ別、エンドユーザー別、地域別－展望および予測（2022年～2028年）Global Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type, By Product Type, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
|
|
|||||||
価格
| インターベンショナルオンコロジーの世界市場－市場規模、シェア、業界動向：がんタイプ別、製品タイプ別、エンドユーザー別、地域別－展望および予測（2022年～2028年） |
|
出版日: 2022年06月30日
発行: KBV Research
ページ情報: 英文 242 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
世界のインターベンショナルオンコロジーの市場規模は、予測期間中に6.2%のCAGRで成長し、2028年には29億米ドルに達すると予測されます。
インターベンショナルオンコロジーがもたらす効率化と早期回復、低侵襲手術への嗜好の変化は、インターベンショナルオンコロジー市場の成長を促進しています。しかし、治療効果を維持するための臨床データの制限が、市場の成長を抑制しています。
当レポートでは、世界のインターベンショナルオンコロジー市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。
目次
第1章 市場の範囲と調査手法
第2章 市場概要
- イントロダクション
- 市場に影響を与える主な要因
第3章 世界のインターベンショナルオンコロジー市場：がんタイプ別
- 世界の肝臓がん市場：地域別
- 世界の肺がん市場：地域別
- 世界の腎臓がん市場：地域別
- 世界の乳がん市場：地域別
- 世界の前立腺がん市場：地域別
- 世界の骨転移市場：地域別
- 世界のその他市場：地域別
第4章 世界のインターベンショナルオンコロジー市場：製品タイプ別
- 世界の塞栓デバイス市場：地域別
- 世界のアブレーションデバイス市場：地域別
- 世界の支援デバイス市場：地域別
第5章 世界のインターベンショナルオンコロジー市場：エンドユーザー別
- 世界の病院市場：地域別
- 世界の外来手術センター市場：地域別
- 世界の研究機関・学術機関市場：地域別
第6章 世界のインターベンショナルオンコロジー市場：地域別
- 北米のインターベンショナルオンコロジー市場
- 欧州のインターベンショナルオンコロジー市場
- アジア太平洋のインターベンショナルオンコロジー市場
- ラテンアメリカ・中東・アフリカのインターベンショナルオンコロジー市場
第7章 企業プロファイル
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc.(Cook Group)
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson(Johnson & Johnson Services, Inc.)
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- HealthTronics, Inc.(Altaris Capital Partners, LLC)
図表
LIST OF TABLES
- TABLE 1 Global Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 2 Global Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 3 Global Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 4 Global Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 5 Global Liver Cancer Market by Region, 2018 - 2021, USD Million
- TABLE 6 Global Liver Cancer Market by Region, 2022 - 2028, USD Million
- TABLE 7 Global Lung Cancer Market by Region, 2018 - 2021, USD Million
- TABLE 8 Global Lung Cancer Market by Region, 2022 - 2028, USD Million
- TABLE 9 Global Kidney Cancer Market by Region, 2018 - 2021, USD Million
- TABLE 10 Global Kidney Cancer Market by Region, 2022 - 2028, USD Million
- TABLE 11 Global Breast Cancer Market by Region, 2018 - 2021, USD Million
- TABLE 12 Global Breast Cancer Market by Region, 2022 - 2028, USD Million
- TABLE 13 Global Prostate Cancer Market by Region, 2018 - 2021, USD Million
- TABLE 14 Global Prostate Cancer Market by Region, 2022 - 2028, USD Million
- TABLE 15 Global Bone Metastasis Market by Region, 2018 - 2021, USD Million
- TABLE 16 Global Bone Metastasis Market by Region, 2022 - 2028, USD Million
- TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
- TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
- TABLE 19 Global Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 20 Global Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 21 Global Embolization Devices Market by Region, 2018 - 2021, USD Million
- TABLE 22 Global Embolization Devices Market by Region, 2022 - 2028, USD Million
- TABLE 23 Global Ablation Devices Market by Region, 2018 - 2021, USD Million
- TABLE 24 Global Ablation Devices Market by Region, 2022 - 2028, USD Million
- TABLE 25 Global Support Devices Market by Region, 2018 - 2021, USD Million
- TABLE 26 Global Support Devices Market by Region, 2022 - 2028, USD Million
- TABLE 27 Global Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 28 Global Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 29 Global Hospitals Market by Region, 2018 - 2021, USD Million
- TABLE 30 Global Hospitals Market by Region, 2022 - 2028, USD Million
- TABLE 31 Global Ambulatory Surgery Centers Market by Region, 2018 - 2021, USD Million
- TABLE 32 Global Ambulatory Surgery Centers Market by Region, 2022 - 2028, USD Million
- TABLE 33 Global Research & Academic Institutes Market by Region, 2018 - 2021, USD Million
- TABLE 34 Global Research & Academic Institutes Market by Region, 2022 - 2028, USD Million
- TABLE 35 Global Interventional Oncology Market by Region, 2018 - 2021, USD Million
- TABLE 36 Global Interventional Oncology Market by Region, 2022 - 2028, USD Million
- TABLE 37 North America Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 38 North America Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 39 North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 40 North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 41 North America Liver Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 42 North America Liver Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 43 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 44 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 45 North America Kidney Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 46 North America Kidney Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 47 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 48 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 49 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 50 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 51 North America Bone Metastasis Market by Country, 2018 - 2021, USD Million
- TABLE 52 North America Bone Metastasis Market by Country, 2022 - 2028, USD Million
- TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 55 North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 56 North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 57 North America Embolization Devices Market by Country, 2018 - 2021, USD Million
- TABLE 58 North America Embolization Devices Market by Country, 2022 - 2028, USD Million
- TABLE 59 North America Ablation Devices Market by Country, 2018 - 2021, USD Million
- TABLE 60 North America Ablation Devices Market by Country, 2022 - 2028, USD Million
- TABLE 61 North America Support Devices Market by Country, 2018 - 2021, USD Million
- TABLE 62 North America Support Devices Market by Country, 2022 - 2028, USD Million
- TABLE 63 North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 64 North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 65 North America Hospitals Market by Country, 2018 - 2021, USD Million
- TABLE 66 North America Hospitals Market by Country, 2022 - 2028, USD Million
- TABLE 67 North America Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
- TABLE 68 North America Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
- TABLE 69 North America Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 70 North America Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 71 North America Interventional Oncology Market by Country, 2018 - 2021, USD Million
- TABLE 72 North America Interventional Oncology Market by Country, 2022 - 2028, USD Million
- TABLE 73 US Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 74 US Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 75 US Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 76 US Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 77 US Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 78 US Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 79 US Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 80 US Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 81 Canada Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 82 Canada Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 83 Canada Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 84 Canada Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 85 Canada Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 86 Canada Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 87 Canada Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 88 Canada Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 89 Mexico Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 90 Mexico Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 91 Mexico Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 92 Mexico Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 93 Mexico Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 94 Mexico Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 95 Mexico Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 96 Mexico Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 97 Rest of North America Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 98 Rest of North America Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 99 Rest of North America Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 100 Rest of North America Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 101 Rest of North America Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 102 Rest of North America Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 103 Rest of North America Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 104 Rest of North America Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 105 Europe Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 106 Europe Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 107 Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 108 Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 109 Europe Liver Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 110 Europe Liver Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 111 Europe Lung Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 112 Europe Lung Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 113 Europe Kidney Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 114 Europe Kidney Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 115 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 116 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 117 Europe Prostate Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 118 Europe Prostate Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 119 Europe Bone Metastasis Market by Country, 2018 - 2021, USD Million
- TABLE 120 Europe Bone Metastasis Market by Country, 2022 - 2028, USD Million
- TABLE 121 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 122 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 123 Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 124 Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 125 Europe Embolization Devices Market by Country, 2018 - 2021, USD Million
- TABLE 126 Europe Embolization Devices Market by Country, 2022 - 2028, USD Million
- TABLE 127 Europe Ablation Devices Market by Country, 2018 - 2021, USD Million
- TABLE 128 Europe Ablation Devices Market by Country, 2022 - 2028, USD Million
- TABLE 129 Europe Support Devices Market by Country, 2018 - 2021, USD Million
- TABLE 130 Europe Support Devices Market by Country, 2022 - 2028, USD Million
- TABLE 131 Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 132 Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 133 Europe Hospitals Market by Country, 2018 - 2021, USD Million
- TABLE 134 Europe Hospitals Market by Country, 2022 - 2028, USD Million
- TABLE 135 Europe Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
- TABLE 136 Europe Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
- TABLE 137 Europe Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 138 Europe Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 139 Europe Interventional Oncology Market by Country, 2018 - 2021, USD Million
- TABLE 140 Europe Interventional Oncology Market by Country, 2022 - 2028, USD Million
- TABLE 141 Germany Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 142 Germany Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 143 Germany Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 144 Germany Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 145 Germany Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 146 Germany Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 147 Germany Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 148 Germany Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 149 UK Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 150 UK Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 151 UK Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 152 UK Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 153 UK Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 154 UK Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 155 UK Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 156 UK Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 157 France Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 158 France Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 159 France Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 160 France Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 161 France Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 162 France Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 163 France Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 164 France Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 165 Russia Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 166 Russia Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 167 Russia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 168 Russia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 169 Russia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 170 Russia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 171 Russia Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 172 Russia Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 173 Spain Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 174 Spain Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 175 Spain Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 176 Spain Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 177 Spain Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 178 Spain Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 179 Spain Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 180 Spain Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 181 Italy Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 182 Italy Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 183 Italy Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 184 Italy Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 185 Italy Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 186 Italy Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 187 Italy Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 188 Italy Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 189 Rest of Europe Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 190 Rest of Europe Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 191 Rest of Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 192 Rest of Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 193 Rest of Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 194 Rest of Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 195 Rest of Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 196 Rest of Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 197 Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 198 Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 199 Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 200 Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 201 Asia Pacific Liver Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 202 Asia Pacific Liver Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 203 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 204 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 205 Asia Pacific Kidney Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 206 Asia Pacific Kidney Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 207 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 208 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 209 Asia Pacific Prostate Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 210 Asia Pacific Prostate Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 211 Asia Pacific Bone Metastasis Market by Country, 2018 - 2021, USD Million
- TABLE 212 Asia Pacific Bone Metastasis Market by Country, 2022 - 2028, USD Million
- TABLE 213 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 214 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 215 Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 216 Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 217 Asia Pacific Embolization Devices Market by Country, 2018 - 2021, USD Million
- TABLE 218 Asia Pacific Embolization Devices Market by Country, 2022 - 2028, USD Million
- TABLE 219 Asia Pacific Ablation Devices Market by Country, 2018 - 2021, USD Million
- TABLE 220 Asia Pacific Ablation Devices Market by Country, 2022 - 2028, USD Million
- TABLE 221 Asia Pacific Support Devices Market by Country, 2018 - 2021, USD Million
- TABLE 222 Asia Pacific Support Devices Market by Country, 2022 - 2028, USD Million
- TABLE 223 Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 224 Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 225 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
- TABLE 226 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
- TABLE 227 Asia Pacific Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
- TABLE 228 Asia Pacific Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
- TABLE 229 Asia Pacific Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 230 Asia Pacific Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 231 Asia Pacific Interventional Oncology Market by Country, 2018 - 2021, USD Million
- TABLE 232 Asia Pacific Interventional Oncology Market by Country, 2022 - 2028, USD Million
- TABLE 233 China Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 234 China Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 235 China Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 236 China Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 237 China Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 238 China Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 239 China Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 240 China Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 241 Japan Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 242 Japan Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 243 Japan Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 244 Japan Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 245 Japan Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 246 Japan Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 247 Japan Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 248 Japan Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 249 India Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 250 India Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 251 India Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 252 India Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 253 India Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 254 India Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 255 India Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 256 India Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 257 South Korea Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 258 South Korea Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 259 South Korea Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 260 South Korea Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 261 South Korea Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 262 South Korea Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 263 South Korea Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 264 South Korea Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 265 Singapore Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 266 Singapore Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 267 Singapore Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 268 Singapore Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 269 Singapore Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 270 Singapore Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 271 Singapore Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 272 Singapore Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 273 Malaysia Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 274 Malaysia Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 275 Malaysia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 276 Malaysia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 277 Malaysia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 278 Malaysia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 279 Malaysia Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 280 Malaysia Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 281 Rest of Asia Pacific Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 282 Rest of Asia Pacific Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 283 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 284 Rest of Asia Pacific Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 285 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 286 Rest of Asia Pacific Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 287 Rest of Asia Pacific Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 288 Rest of Asia Pacific Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 289 LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 290 LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 291 LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 292 LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 293 LAMEA Liver Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 294 LAMEA Liver Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 295 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 296 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 297 LAMEA Kidney Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 298 LAMEA Kidney Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 299 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 300 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 301 LAMEA Prostate Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 302 LAMEA Prostate Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 303 LAMEA Bone Metastasis Market by Country, 2018 - 2021, USD Million
- TABLE 304 LAMEA Bone Metastasis Market by Country, 2022 - 2028, USD Million
- TABLE 305 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 306 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 307 LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 308 LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 309 LAMEA Embolization Devices Market by Country, 2018 - 2021, USD Million
- TABLE 310 LAMEA Embolization Devices Market by Country, 2022 - 2028, USD Million
- TABLE 311 LAMEA Ablation Devices Market by Country, 2018 - 2021, USD Million
- TABLE 312 LAMEA Ablation Devices Market by Country, 2022 - 2028, USD Million
- TABLE 313 LAMEA Support Devices Market by Country, 2018 - 2021, USD Million
- TABLE 314 LAMEA Support Devices Market by Country, 2022 - 2028, USD Million
- TABLE 315 LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 316 LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 317 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
- TABLE 318 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
- TABLE 319 LAMEA Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
- TABLE 320 LAMEA Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
- TABLE 321 LAMEA Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 322 LAMEA Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 323 LAMEA Interventional Oncology Market by Country, 2018 - 2021, USD Million
- TABLE 324 LAMEA Interventional Oncology Market by Country, 2022 - 2028, USD Million
- TABLE 325 Brazil Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 326 Brazil Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 327 Brazil Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 328 Brazil Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 329 Brazil Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 330 Brazil Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 331 Brazil Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 332 Brazil Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 333 Argentina Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 334 Argentina Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 335 Argentina Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 336 Argentina Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 337 Argentina Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 338 Argentina Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 339 Argentina Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 340 Argentina Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 341 UAE Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 342 UAE Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 343 UAE Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 344 UAE Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 345 UAE Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 346 UAE Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 347 UAE Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 348 UAE Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 349 Saudi Arabia Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 350 Saudi Arabia Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 351 Saudi Arabia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 352 Saudi Arabia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 353 Saudi Arabia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 354 Saudi Arabia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 355 Saudi Arabia Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 356 Saudi Arabia Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 357 South Africa Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 358 South Africa Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 359 South Africa Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 360 South Africa Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 361 South Africa Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 362 South Africa Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 363 South Africa Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 364 South Africa Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 365 Nigeria Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 366 Nigeria Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 367 Nigeria Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 368 Nigeria Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 369 Nigeria Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 370 Nigeria Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 371 Nigeria Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 372 Nigeria Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 373 Rest of LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
- TABLE 374 Rest of LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
- TABLE 375 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
- TABLE 376 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
- TABLE 377 Rest of LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
- TABLE 378 Rest of LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
- TABLE 379 Rest of LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
- TABLE 380 Rest of LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
- TABLE 381 key Information - Boston Scientific Corporation
- TABLE 382 key Information - Teleflex, Inc.
- TABLE 383 key Information - Cook Medical, Inc.
- TABLE 384 Key Information - Medtronic PLC
- TABLE 385 Key Information - Terumo Corporation
- TABLE 386 Key information - Johnson & Johnson
- TABLE 387 Key information - Becton, Dickinson and Company
- TABLE 388 Key Information - AngioDynamics, Inc.
- TABLE 389 Key Information - Merit Medical Systems, Inc.
- TABLE 390 Key Information - HealthTronics, Inc.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Global Interventional Oncology Market share by Cancer Type, 2021
- FIG 3 Global Interventional Oncology Market share by Cancer Type, 2028
- FIG 4 Global Interventional Oncology Market by Cancer Type, 2018 - 2028, USD Million
- FIG 5 Global Interventional Oncology Market share by Product Type, 2021
- FIG 6 Global Interventional Oncology Market share by Product Type, 2028
- FIG 7 Global Interventional Oncology Market by Product Type, 2018 - 2028, USD Million
- FIG 8 Global Interventional Oncology Market share by End User, 2021
- FIG 9 Global Interventional Oncology Market share by End User, 2028
- FIG 10 Global Interventional Oncology Market by End User, 2018 - 2028, USD Million
- FIG 11 Global Interventional Oncology Market share by Region, 2021
- FIG 12 Global Interventional Oncology Market share by Region, 2028
- FIG 13 Global Interventional Oncology Market by Region, 2018 - 2028, USD Million
- FIG 14 SWOT Analysis: Boston Scientific Corporation
- FIG 15 Swot analysis: Medtronic plc
- FIG 16 SWOT analysis: Johnson & Johnson
- FIG 17 Swot analysis: Becton, Dickinson and company
目次
The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period.
Interventional oncology (IO) is an emerging subspecialty that emphasizes on using image-guided processes (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. The three key areas of cancer intervention that IO focuses on are diagnosis, therapy, and symptom relief. Improvements in cross-sectional imaging techniques such as ultrasound, computed tomography (CT), magnetic resonance (MR), and positron emission tomography (PET) have enabled progress in IO (PET).
Because of the rising number of cancer cases among individuals around the world, the interventional oncology market is expected to rise faster in the coming years. Cancer is one of the most rapidly developing health problems, impacting individuals of different ages. Breast cancer & throat cancer are two of the most common types of cancer in individuals. The need for technologically improved cancer management therapy has expanded in tandem with the rise in the number of cancer patients.
Patients with cancer, both adults and children, have benefited from the innovative interventional oncology therapy line. In the coming years, such advancements are expected to have a positive influence on interventional oncology market growth. IO, along with Medical, Surgical, and Radiation Oncology, has successfully established itself as a significant treatment specialism within multidisciplinary oncologic care. In today's cancer care, IO is currently regarded the fourth pillar. Though surgical removal of tumours is typically thought to be the greatest therapy, it is not always achievable owing to the tumor's size, quantity, or location. IO treatments can be used to reduce a tumour, allowing for surgery or interventional treatment. A few patients may be unable to endure open surgery due to their health.
COVID-19 Impact
Patients have constrained themselves from going to visit hospitals and clinics for diagnosis of medical problems other than coronavirus symptoms owing to the increase incidence of coronaviral transmission. As a result, fewer cancer patients have reported to hospitals for treatment. The market is confronted with production and supply chain problems, such as providing items to end users on time and catering to an inconsistent demand for the sector's products and services. Furthermore, a scarcity of talented lab experts to perform diagnostic tests, restricted operations in most businesses, insufficient financing for research & academic institutes, the temporary closure of main academic institutes, a disrupted supply chain, and obstacles in offering a service owing to lockdowns have all contributed to a decrease in the supply of interventional oncology products to end users. As a result, the pandemic is unlikely to have long-term consequences for the basic growth drivers or end consumers in the economy.
Market Growth Factors
More efficiency and quick recovery offered by interventional oncology
While utilizing medical imaging technologies during vascular therapies, radiologists & technologists have a lot of sight. Professionals can accurately identify and treat diseases throughout the operation, which can take less than an hour in some cases. These procedures are also regarded a more effective usage medical resources than major surgery because they are relatively rapid. Because most outpatient processes, particularly interventional radiology, are less costly than inpatient hospital stays, patients often find interventional radiology to be a more cost-effective therapy.
Shifting preference of people towards minimally invasive procedure
Because of the benefits given by these techniques over traditional treatment processes, the demand for minimally invasive procedures has increased significantly in recent years. Fewer operating complications, shorter hospitalization, reduced pain, smaller & more cosmetic incisions, reduced risk of infection, less post-surgical care, and faster recovery are all benefits of minimally invasive procedures. Sophisticated technology is used in minimally invasive treatments to detect and cure a variety of disorders, including cancer. These treatments are intended to remove malignant tumours and lymph nodes from the body without leaving scars.
Market Restraining Factors
Restricted clinical data to maintain therapeutic efficacy
A medication must have comprehensive safety data from Phase I studies, established effectiveness from Phase II trials, and analysis of clinical results better than current therapies from randomized, controlled Phase III trials before it can be introduced as a standard of care. In addition, performing well-controlled clinical trials in interventional oncology procedures, on the other hand, is challenging owing to a dearth of recognized methodology. Chemoembolization, for example, is the most common treatment for hepatocellular cancer. On the other hand, the clinical evidence for chemoembolization is inadequate, and the clinical advantages generated from current trials are smaller than those derived from other cancer treatment alternatives.
Cancer Type Outlook
Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. The liver cancer segment witnessed the maximum revenue share in the interventional oncology market in 2021. Primary liver tumours caused by metastatic cancer can be successfully treated using interventional oncology techniques. Increased research/development efforts using interventional oncology to improve liver cancer therapy, and an increase in the number of instances of liver cancer in the world, are among the factors driving liver sub-growth.
Product Type Outlook
Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. The Ablation devices segment acquired a significant revenue share in the interventional oncology market in 2021. Because of the expanding popularity of minimally invasive treatments and the rising frequency of certain soft tissue malignancies, ablation devices provide a minimally invasive option to conventional surgical treatment of liver, kidney, prostate, and lung cancers.
End User Outlook
Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Hospitals segment acquired the highest revenue share in the interventional oncology market in 2021. The hospital sub-segment might benefit greatly from advancements in healthcare infrastructure and a boom in the adoption of innovative interventional oncology technologies like embolization and ablation devices in hospitals. Additionally, several patients prefer to undergo cancer treatment from hospitals because numerous innovative treatment facilities are housed under one roof, and patients do not have to worry about their treatment.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific recorded a significant revenue share in the interventional oncology market in 2021. This is due to a variety of variables, including an increase in cancer cases amongst people and improved healthcare facilities. The key factors propelling the market of the APAC interventional oncology market are government efforts to raise funding, supportive regulations for the manufacture and marketing of innovative interventional oncology products, increasing healthcare expenditure, growing amount of hospitals and clinics in India and China, broadening research base all over China, India, and Japan, and the rising incidences of surgeries.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)
Scope of the Study
Market Segments covered in the Report:
By Cancer Type
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Bone Metastasis
- Others
By Product Type
- Embolization Devices
- Ablation Devices
- Support Devices
By End User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Interventional Oncology Market, by Cancer Type
- 1.4.2 Global Interventional Oncology Market, by Product Type
- 1.4.3 Global Interventional Oncology Market, by End User
- 1.4.4 Global Interventional Oncology Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Global Interventional Oncology Market by Cancer Type
- 3.1 Global Liver Cancer Market by Region
- 3.2 Global Lung Cancer Market by Region
- 3.3 Global Kidney Cancer Market by Region
- 3.4 Global Breast Cancer Market by Region
- 3.5 Global Prostate Cancer Market by Region
- 3.6 Global Bone Metastasis Market by Region
- 3.7 Global Others Market by Region
Chapter 4. Global Interventional Oncology Market by Product Type
- 4.1 Global Embolization Devices Market by Region
- 4.2 Global Ablation Devices Market by Region
- 4.3 Global Support Devices Market by Region
Chapter 5. Global Interventional Oncology Market by End User
- 5.1 Global Hospitals Market by Region
- 5.2 Global Ambulatory Surgery Centers Market by Region
- 5.3 Global Research & Academic Institutes Market by Region
Chapter 6. Global Interventional Oncology Market by Region
- 6.1 North America Interventional Oncology Market
- 6.1.1 North America Interventional Oncology Market by Cancer Type
- 6.1.1.1 North America Liver Cancer Market by Country
- 6.1.1.2 North America Lung Cancer Market by Country
- 6.1.1.3 North America Kidney Cancer Market by Country
- 6.1.1.4 North America Breast Cancer Market by Country
- 6.1.1.5 North America Prostate Cancer Market by Country
- 6.1.1.6 North America Bone Metastasis Market by Country
- 6.1.1.7 North America Others Market by Country
- 6.1.2 North America Interventional Oncology Market by Product Type
- 6.1.2.1 North America Embolization Devices Market by Country
- 6.1.2.2 North America Ablation Devices Market by Country
- 6.1.2.3 North America Support Devices Market by Country
- 6.1.3 North America Interventional Oncology Market by End User
- 6.1.3.1 North America Hospitals Market by Country
- 6.1.3.2 North America Ambulatory Surgery Centers Market by Country
- 6.1.3.3 North America Research & Academic Institutes Market by Country
- 6.1.4 North America Interventional Oncology Market by Country
- 6.1.4.1 US Interventional Oncology Market
- 6.1.4.1.1 US Interventional Oncology Market by Cancer Type
- 6.1.4.1.2 US Interventional Oncology Market by Product Type
- 6.1.4.1.3 US Interventional Oncology Market by End User
- 6.1.4.2 Canada Interventional Oncology Market
- 6.1.4.2.1 Canada Interventional Oncology Market by Cancer Type
- 6.1.4.2.2 Canada Interventional Oncology Market by Product Type
- 6.1.4.2.3 Canada Interventional Oncology Market by End User
- 6.1.4.3 Mexico Interventional Oncology Market
- 6.1.4.3.1 Mexico Interventional Oncology Market by Cancer Type
- 6.1.4.3.2 Mexico Interventional Oncology Market by Product Type
- 6.1.4.3.3 Mexico Interventional Oncology Market by End User
- 6.1.4.4 Rest of North America Interventional Oncology Market
- 6.1.4.4.1 Rest of North America Interventional Oncology Market by Cancer Type
- 6.1.4.4.2 Rest of North America Interventional Oncology Market by Product Type
- 6.1.4.4.3 Rest of North America Interventional Oncology Market by End User
- 6.1.4.1 US Interventional Oncology Market
- 6.1.1 North America Interventional Oncology Market by Cancer Type
- 6.2 Europe Interventional Oncology Market
- 6.2.1 Europe Interventional Oncology Market by Cancer Type
- 6.2.1.1 Europe Liver Cancer Market by Country
- 6.2.1.2 Europe Lung Cancer Market by Country
- 6.2.1.3 Europe Kidney Cancer Market by Country
- 6.2.1.4 Europe Breast Cancer Market by Country
- 6.2.1.5 Europe Prostate Cancer Market by Country
- 6.2.1.6 Europe Bone Metastasis Market by Country
- 6.2.1.7 Europe Others Market by Country
- 6.2.2 Europe Interventional Oncology Market by Product Type
- 6.2.2.1 Europe Embolization Devices Market by Country
- 6.2.2.2 Europe Ablation Devices Market by Country
- 6.2.2.3 Europe Support Devices Market by Country
- 6.2.3 Europe Interventional Oncology Market by End User
- 6.2.3.1 Europe Hospitals Market by Country
- 6.2.3.2 Europe Ambulatory Surgery Centers Market by Country
- 6.2.3.3 Europe Research & Academic Institutes Market by Country
- 6.2.4 Europe Interventional Oncology Market by Country
- 6.2.4.1 Germany Interventional Oncology Market
- 6.2.4.1.1 Germany Interventional Oncology Market by Cancer Type
- 6.2.4.1.2 Germany Interventional Oncology Market by Product Type
- 6.2.4.1.3 Germany Interventional Oncology Market by End User
- 6.2.4.2 UK Interventional Oncology Market
- 6.2.4.2.1 UK Interventional Oncology Market by Cancer Type
- 6.2.4.2.2 UK Interventional Oncology Market by Product Type
- 6.2.4.2.3 UK Interventional Oncology Market by End User
- 6.2.4.3 France Interventional Oncology Market
- 6.2.4.3.1 France Interventional Oncology Market by Cancer Type
- 6.2.4.3.2 France Interventional Oncology Market by Product Type
- 6.2.4.3.3 France Interventional Oncology Market by End User
- 6.2.4.4 Russia Interventional Oncology Market
- 6.2.4.4.1 Russia Interventional Oncology Market by Cancer Type
- 6.2.4.4.2 Russia Interventional Oncology Market by Product Type
- 6.2.4.4.3 Russia Interventional Oncology Market by End User
- 6.2.4.5 Spain Interventional Oncology Market
- 6.2.4.5.1 Spain Interventional Oncology Market by Cancer Type
- 6.2.4.5.2 Spain Interventional Oncology Market by Product Type
- 6.2.4.5.3 Spain Interventional Oncology Market by End User
- 6.2.4.6 Italy Interventional Oncology Market
- 6.2.4.6.1 Italy Interventional Oncology Market by Cancer Type
- 6.2.4.6.2 Italy Interventional Oncology Market by Product Type
- 6.2.4.6.3 Italy Interventional Oncology Market by End User
- 6.2.4.7 Rest of Europe Interventional Oncology Market
- 6.2.4.7.1 Rest of Europe Interventional Oncology Market by Cancer Type
- 6.2.4.7.2 Rest of Europe Interventional Oncology Market by Product Type
- 6.2.4.7.3 Rest of Europe Interventional Oncology Market by End User
- 6.2.4.1 Germany Interventional Oncology Market
- 6.2.1 Europe Interventional Oncology Market by Cancer Type
- 6.3 Asia Pacific Interventional Oncology Market
- 6.3.1 Asia Pacific Interventional Oncology Market by Cancer Type
- 6.3.1.1 Asia Pacific Liver Cancer Market by Country
- 6.3.1.2 Asia Pacific Lung Cancer Market by Country
- 6.3.1.3 Asia Pacific Kidney Cancer Market by Country
- 6.3.1.4 Asia Pacific Breast Cancer Market by Country
- 6.3.1.5 Asia Pacific Prostate Cancer Market by Country
- 6.3.1.6 Asia Pacific Bone Metastasis Market by Country
- 6.3.1.7 Asia Pacific Others Market by Country
- 6.3.2 Asia Pacific Interventional Oncology Market by Product Type
- 6.3.2.1 Asia Pacific Embolization Devices Market by Country
- 6.3.2.2 Asia Pacific Ablation Devices Market by Country
- 6.3.2.3 Asia Pacific Support Devices Market by Country
- 6.3.3 Asia Pacific Interventional Oncology Market by End User
- 6.3.3.1 Asia Pacific Hospitals Market by Country
- 6.3.3.2 Asia Pacific Ambulatory Surgery Centers Market by Country
- 6.3.3.3 Asia Pacific Research & Academic Institutes Market by Country
- 6.3.4 Asia Pacific Interventional Oncology Market by Country
- 6.3.4.1 China Interventional Oncology Market
- 6.3.4.1.1 China Interventional Oncology Market by Cancer Type
- 6.3.4.1.2 China Interventional Oncology Market by Product Type
- 6.3.4.1.3 China Interventional Oncology Market by End User
- 6.3.4.2 Japan Interventional Oncology Market
- 6.3.4.2.1 Japan Interventional Oncology Market by Cancer Type
- 6.3.4.2.2 Japan Interventional Oncology Market by Product Type
- 6.3.4.2.3 Japan Interventional Oncology Market by End User
- 6.3.4.3 India Interventional Oncology Market
- 6.3.4.3.1 India Interventional Oncology Market by Cancer Type
- 6.3.4.3.2 India Interventional Oncology Market by Product Type
- 6.3.4.3.3 India Interventional Oncology Market by End User
- 6.3.4.4 South Korea Interventional Oncology Market
- 6.3.4.4.1 South Korea Interventional Oncology Market by Cancer Type
- 6.3.4.4.2 South Korea Interventional Oncology Market by Product Type
- 6.3.4.4.3 South Korea Interventional Oncology Market by End User
- 6.3.4.5 Singapore Interventional Oncology Market
- 6.3.4.5.1 Singapore Interventional Oncology Market by Cancer Type
- 6.3.4.5.2 Singapore Interventional Oncology Market by Product Type
- 6.3.4.5.3 Singapore Interventional Oncology Market by End User
- 6.3.4.6 Malaysia Interventional Oncology Market
- 6.3.4.6.1 Malaysia Interventional Oncology Market by Cancer Type
- 6.3.4.6.2 Malaysia Interventional Oncology Market by Product Type
- 6.3.4.6.3 Malaysia Interventional Oncology Market by End User
- 6.3.4.7 Rest of Asia Pacific Interventional Oncology Market
- 6.3.4.7.1 Rest of Asia Pacific Interventional Oncology Market by Cancer Type
- 6.3.4.7.2 Rest of Asia Pacific Interventional Oncology Market by Product Type
- 6.3.4.7.3 Rest of Asia Pacific Interventional Oncology Market by End User
- 6.3.4.1 China Interventional Oncology Market
- 6.3.1 Asia Pacific Interventional Oncology Market by Cancer Type
- 6.4 LAMEA Interventional Oncology Market
- 6.4.1 LAMEA Interventional Oncology Market by Cancer Type
- 6.4.1.1 LAMEA Liver Cancer Market by Country
- 6.4.1.2 LAMEA Lung Cancer Market by Country
- 6.4.1.3 LAMEA Kidney Cancer Market by Country
- 6.4.1.4 LAMEA Breast Cancer Market by Country
- 6.4.1.5 LAMEA Prostate Cancer Market by Country
- 6.4.1.6 LAMEA Bone Metastasis Market by Country
- 6.4.1.7 LAMEA Others Market by Country
- 6.4.2 LAMEA Interventional Oncology Market by Product Type
- 6.4.2.1 LAMEA Embolization Devices Market by Country
- 6.4.2.2 LAMEA Ablation Devices Market by Country
- 6.4.2.3 LAMEA Support Devices Market by Country
- 6.4.3 LAMEA Interventional Oncology Market by End User
- 6.4.3.1 LAMEA Hospitals Market by Country
- 6.4.3.2 LAMEA Ambulatory Surgery Centers Market by Country
- 6.4.3.3 LAMEA Research & Academic Institutes Market by Country
- 6.4.4 LAMEA Interventional Oncology Market by Country
- 6.4.4.1 Brazil Interventional Oncology Market
- 6.4.4.1.1 Brazil Interventional Oncology Market by Cancer Type
- 6.4.4.1.2 Brazil Interventional Oncology Market by Product Type
- 6.4.4.1.3 Brazil Interventional Oncology Market by End User
- 6.4.4.2 Argentina Interventional Oncology Market
- 6.4.4.2.1 Argentina Interventional Oncology Market by Cancer Type
- 6.4.4.2.2 Argentina Interventional Oncology Market by Product Type
- 6.4.4.2.3 Argentina Interventional Oncology Market by End User
- 6.4.4.3 UAE Interventional Oncology Market
- 6.4.4.3.1 UAE Interventional Oncology Market by Cancer Type
- 6.4.4.3.2 UAE Interventional Oncology Market by Product Type
- 6.4.4.3.3 UAE Interventional Oncology Market by End User
- 6.4.4.4 Saudi Arabia Interventional Oncology Market
- 6.4.4.4.1 Saudi Arabia Interventional Oncology Market by Cancer Type
- 6.4.4.4.2 Saudi Arabia Interventional Oncology Market by Product Type
- 6.4.4.4.3 Saudi Arabia Interventional Oncology Market by End User
- 6.4.4.5 South Africa Interventional Oncology Market
- 6.4.4.5.1 South Africa Interventional Oncology Market by Cancer Type
- 6.4.4.5.2 South Africa Interventional Oncology Market by Product Type
- 6.4.4.5.3 South Africa Interventional Oncology Market by End User
- 6.4.4.6 Nigeria Interventional Oncology Market
- 6.4.4.6.1 Nigeria Interventional Oncology Market by Cancer Type
- 6.4.4.6.2 Nigeria Interventional Oncology Market by Product Type
- 6.4.4.6.3 Nigeria Interventional Oncology Market by End User
- 6.4.4.7 Rest of LAMEA Interventional Oncology Market
- 6.4.4.7.1 Rest of LAMEA Interventional Oncology Market by Cancer Type
- 6.4.4.7.2 Rest of LAMEA Interventional Oncology Market by Product Type
- 6.4.4.7.3 Rest of LAMEA Interventional Oncology Market by End User
- 6.4.4.1 Brazil Interventional Oncology Market
- 6.4.1 LAMEA Interventional Oncology Market by Cancer Type
Chapter 7. Company Profiles
- 7.1 Boston Scientific Corporation
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Teleflex, Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.3 Cook Medical, Inc. (Cook Group)
- 7.3.1 Company Overview
- 7.4 Medtronic PLC
- 7.4.1 Company overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent Strategies and Developments
- 7.4.5.1 Product Launches and Product Expansions:
- 7.4.6 SWOT Analysis
- 7.5 Terumo Corporation
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Regional Analysis
- 7.5.5 Recent Strategies and Developments
- 7.5.5.1 Partnerships, Collaborations and Agreements:
- 7.5.5.2 Acquisitions and Mergers:
- 7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental &Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
- 7.7 Becton, Dickinson and Company
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 SWOT Analysis
- 7.8 AngioDynamics, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.9 Merit Medical Systems, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
- 7.10.1 Company Overview
